Kimberly-Clark Corporation (KMB) Stock Price, News, Analysis

Technical Score (1D)

SELL

News Sentiment

BULLISH

Kimberly-Clark reported a 3% growth in volume and mix, signaling positive operational momentum driven by effective product positioning and sales execution. Investors are now focused on the sustainability of this growth rate in the current market. This recent performance follows a period where Kimberly-Clark's FY2025 revenue saw a slight decrease to $16.4 billion, with net income also declining. These headwinds were attributed to shifting consumer demand and high commodity costs. The company's product portfolio remains centered on essential personal and family care items, such as Huggies and Kleenex. A notable risk identified is customer concentration, with Walmart accounting for approximately 16% of net sales. The ongoing challenges of high commodity costs and intense competition remain key factors to monitor.

KMB|Company Info

Sector

Consumer Defensive

Industry

Household & Personal Products

Exchange

NMS

Country

United States

Website

kimberly-clark.com

Symbol

KMB

Description

Kimberly-Clark Corporation is a consumer staples company primarily focused on producing and distributing personal care products. The company's operations are divided into three key segments: North America, International Personal Care, and International Family Care and Professional. Kimberly-Clark's product portfolio includes well-known brands such as Huggies, Kleenex, and Kotex, encompassing a wide range of items from diapers and feminine hygiene products to facial tissue and paper towels. These products are sold through various retail channels, including supermarkets, drugstores, and online platforms, as well as directly to businesses and institutions. Founded in 1872 and based in Dallas, Texas, Kimberly-Clark has a long history of providing essential consumer goods.

KMB|Earnings Snapshot

Earnings Summary

Kimberly-Clark Corporation is a prominent consumer staples company, established in 1872 and headquartered in Dallas, Texas. It specializes in the production and distribution of personal care products, operating through segments like North America, International Personal Care, and International Family Care and Professional. The company's well-recognized brands, including Huggies, Kleenex, and Kotex, cater to essential consumer needs across various retail and institutional channels. Kimberly-Clark operates within the Consumer Defensive sector, specifically in the Household & Personal Products industry, a space characterized by consistent demand for its product categories. Examining the most recent earnings data, Kimberly-Clark's performance shows a mixed trend in the last four reported quarters. In Q1 2026, the company reported an actual EPS of $1.97 against an estimate of $2.07, marking a miss, with actual revenue at $4.163 billion against an estimate of $4.253 billion. This follows a Q4 2025 where actual EPS was $1.86, exceeding the estimate of $1.83, though actual revenue of $4.08 billion fell short of the $4.131 billion estimate. Prior to this, Q3 2025 saw actual EPS of $1.82 versus an estimate of $1.75, and Q2 2025 reported actual EPS of $1.92 against an estimate of $1.66. This pattern indicates an inconsistency in meeting analyst expectations for both earnings per share and revenue in recent periods. Historically, Kimberly-Clark's year-over-year growth trajectory has shown variability. The company has demonstrated a pattern of beating EPS estimates in some quarters, such as Q2 and Q3 2025, while missing in others like Q1 2026. Revenue performance has also been inconsistent, with misses observed in Q4 2025 and Q1 2026, despite some quarters showing revenue growth. This suggests that while the company's core business remains stable, fluctuations in market conditions or operational factors can impact its ability to consistently meet financial projections. Recent news indicates significant strategic movements for Kimberly-Clark. The company has received unconditional approval from the European Commission for Suzano's acquisition of its Industrial and Consumer Paper (IFP) business, following similar EU approval for its international tissue business. Additionally, regulatory clearance has been obtained from India's Competition Commission for Kimberly-Clark's acquisition of sole control over Kenvue, addressing potential competitive overlaps. These developments, alongside the release of shareholder and analyst call transcripts, suggest a period of portfolio reshaping and increased transparency in corporate communications. Looking ahead, investors will be watching for the successful integration of Kenvue in India and the completion of the divestitures of its paper businesses. Key will be how these strategic shifts impact future revenue streams and profitability, particularly in light of the mixed earnings performance in recent quarters. Monitoring any further analyst commentary following these regulatory milestones and the company's own forward-looking statements will be crucial for understanding the evolving financial landscape.

Read full report

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$2.02	-	-
Q1'26	$2.07	$1.97	-4.9%
Q4'25	$1.83	$1.86	+1.7%
Q3'25	$1.75	$1.82	+3.9%
Q2'25	$1.66	$1.92	+16.0%
Q1'25	$1.89	$1.93	+2.0%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$4.2B	-	-
Q1'26	$4.3B	$4.2B	-2.1%
Q4'25	$4.1B	$4.1B	-1.2%
Q3'25	-	$4.2B	-
Q2'25	-	$4.2B	-
Q1'25	-	$4.8B	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

→

Market Data

KMB Stock Snapshot

KMB is currently trading at $97.87, giving Kimberly-Clark Corporation a market cap of 33.24B and a P/E ratio of 15.7. Today's range spans $97.14–$100.95, with shares opening at $100.25 and moving up $0.30 (0.3%) from the prior close. DailyIQ's technical score sits at 32/100 (SELL) with a news sentiment reading of 77/100.

Over the past year KMB has traded between $92.42 and $144.31 - the current price is +5.9% off the 52-week low and -32.2% from the high. 22 analysts cover the stock with a Hold consensus and a mean 12-month target of $114.27 (range $90.00–$162.00), implying upside of +16.8%.

Earnings estimate risk is at the forefront for Kimberly-Clark Corporation (KMB) - a large-cap Consumer Defensive name (33.24B market cap) showing a SELL (32/100) alongside bullish sentiment (77/100) often flags a period where consensus estimates are still catching down to what the market is already pricing in. Price: $97.87 (near 52-week lows in $92.42–$144.31). (P/E: 15.7) Active managers who track the technical-fundamental gap tend to position ahead of the revision, not after it.

When a large-cap Consumer Defensive name with 33.24B in capitalization prints a SELL signal (32/100) alongside bullish news sentiment (77/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $97.87 (near 52-week lows in the $92.42–$144.31 range), the structural support levels are where that sponsorship question gets answered.

News Sentiment Analysis

Sentiment gathered from recent headlines

77/100

Strong NegativeNeutralStrong Positive

BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

Kimberly-Clark (KMB) is achieving notable growth, driven by a combination of product innovation and strategic pricing. These initiatives are proving effective in offsetting inflationary pressures and operational challenges. The company's ability to leverage both volume and mix improvements suggests a resilient business model.

What did this article say?

This article compares Kimberly-Clark (KMB) with The Clorox Company (CLX), highlighting KMB's focus on paper-based personal care essentials like Huggies and Kleenex. It notes KMB's revenue decline in FY2025 to $16.4 billion and a dip in net income, attributed to shifting consumer demand and high commodity costs. A significant customer concentration risk is identified, with Walmart representing approximately 16% of net sales.

What did this article say?

DonerColle Partners has appointed Mariana O'Kelly as its first Chief Creative Officer, a move that will impact creative direction across its agencies, including work for Kimberly-Clark brands. O'Kelly brings extensive experience leading creative for major consumer brands. Her appointment signals a renewed focus on creative strategy to drive business results for clients.

What did this article say?

Global companies, including Kimberly-Clark (KMB), anticipate that artificial intelligence will significantly accelerate the creation of intellectual property and patents within their Indian technology centers. This trend highlights India's evolving role as a hub for innovation, with AI enabling staff to shift from routine tasks to more complex development and proprietary technology building. The increasing output of IPs and patents from these centers underscores a strategic shift driven by technological advancements.

What did this article say?

Diamond Hill Capital's Large Cap Strategy initiated a position in Kimberly-Clark (KMB) following a post-acquisition decline. The strategy's Q1 performance lagged the Russell 1000 Value Index, though stock selection in industrials and consumer discretionary provided a positive impact. This move suggests a belief in KMB's valuation after a market reaction.

What did this article say?

Kimberly-Clark (KMB) is trading near its 52-week lows, presenting a potential buying opportunity for investors. The company reported positive Q1 organic growth and is expected to benefit from synergies related to the Kenvue merger. With a current yield of 5.2%, the stock is positioned as a dividend aristocrat poised for a rebound.

What did this article say?

This article explores whether Kimberly-Clark (KMB) presents a compelling investment opportunity among NASDAQ stocks. It frames KMB as a potential value play, suggesting a review of its current market position and financial health is warranted for investors seeking undervalued assets.

What did this article say?

Kimberly-Clark is strategically reshaping its business through the acquisition of Kenvue's consumer health brands and a realignment of its Suzano joint venture, including divestitures of lower-growth operations. The company is also launching new Pull-Ups Learning Layer technology nationwide. These moves signal management's intent to focus on higher-margin health categories and refreshed core products within the mature consumer staples sector. Investor focus will be on the successful integration of Kenvue and execution of the joint venture changes.

What did this article say?

Kimberly-Clark's stock has experienced mixed performance, showing a slight gain over the past month but a decline across the last three months and year. This price action has led to increased scrutiny of the company's valuation and underlying fundamentals. The current trading environment suggests a period of reassessment for investors tracking KMB.

What did this article say?

This article highlights KMB as a potential deep-value opportunity for investors, noting its recent 52-week lows. Despite broader market pressures and rising consumer costs, the piece suggests that certain consumer-focused companies are still delivering strong profits. The focus is on identifying undervalued assets amidst a market showing pockets of both strength and weakness.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

KMB·Kimberly-Clark Corporation

EPS

Revenue

KMB Stock Snapshot

News Sentiment Analysis

Recent News Coverage

Discover More

News Sentiment Analysis

Recent News Coverage

Discover More